Gene · 1749
Papers1,688
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,688
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of high-dose methotrexate on bone metabolism: A narrative literature review. | Bone Rep | 2026 | 41732177 | PubTator, text mining | PubMed |
| Acellular dental pulp and allogeneic cells for strategic pulp regeneration. | Tissue Cell | 2026 | 41687189 | PubTator, text mining | PubMed |
| Intrinsic tumor factors and extrinsic environmental and social exposures contribute to endometrial cancer recurrence patterns. | Res Sq | 2026 | 41646408 | PubTator, text mining | PubMed |
| Spatiotemporal Regulation and Lineage Specification in Embryonic Endochondral Ossification. | Int J Mol Sci | 2026 | 41596573 | PubTator, text mining | PubMed |
| Single-Cell Regulatory Network Analysis Identifies Adjunctive Drug Candidates in Early Risankizumab-Treated Psoriasis. | Curr Pharm Des | 2026 | 41574526 | PubTator, text mining | PubMed |
| DLX5 regulates nasal Epithelial Mesenchymal Transition and inflammation in EosCRSwNPs via the COL1A1-mediated Wnt/β-catenin Signaling. | Int Immunopharmacol | 2026 | 41520558 | PubTator, text mining | PubMed |
| FAM20A Deficiency Drives Transcriptomic Dysregulation and Functional Impairment in Gingival Fibroblasts. | Cell Prolif | 2026 | 40693438 | PubTator, text mining | PubMed |
| Investigating Novel Biomarkers in Endometrial Cancer - A Study on RT-qPCR and Immunohistochemistry. | Iran J Allergy Asthma Immunol | 2025 | 41266266 | PubTator, text mining | PubMed |
| Exploring the potential of stem cells from the apical papilla (SCAPs) in regenerative medicine: advantages, applications, challenges and opportunities. | Stem Cell Res Ther | 2025 | 41204348 | PubTator, text mining | PubMed |
| A Circular Aptamer-ASO Chimera for Activating DLX5-Regulated Osteogenesis through Targeted Inhibition of STAT5A Expression. | ACS Chem Biol | 2025 | 41194772 | PubTator, text mining | PubMed |
| Distal-less homeobox 5 transactivated by MYCN contributes to progression of neuroblastoma through AKT signaling pathway. | Cell Signal | 2025 | 41135749 | PubTator, text mining | PubMed |
| Magnetized Cell-Scaffold Constructs for Bone Tissue Engineering: Advances in Fabrication and Magnetic Stimulation. | Adv Sci (Weinh) | 2025 | 41017533 | PubTator, text mining | PubMed |
| Super-Enhancer-Mediated DLX5 Activation Defines Regulatory Mechanisms in Human Embryonic Stem Cell-Derived Osteoblasts. | Dev Growth Differ | 2025 | 40898609 | PubTator, text mining | PubMed |
| A phenotypic screen for novel small molecules that correct tau-mediated pathologies in human frontotemporal dementia neurons. | Alzheimers Dement | 2025 | 40891380 | PubTator, text mining | PubMed |
| Enhanced Osteogenic Response to an Osteochondral Scaffold Modified with BMP-2 or Strontium-Enriched Amorphous Calcium Phosphate in a Co-Culture In Vitro Model. | J Funct Biomater | 2025 | 40863322 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer. | NPJ Breast Cancer | 2025 | 40858590 | PubTator, text mining | PubMed |
| Endothelial transdifferentiation of glioma stem cells: a literature review. | Acta Neuropathol Commun | 2025 | 40841988 | PubTator, text mining | PubMed |
| Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression. | J Transl Med | 2025 | 40841904 | PubTator, text mining | PubMed |
| Natural bioactive compounds modified with mesenchymal stem cells: new hope for regenerative medicine. | Front Bioeng Biotechnol | 2025 | 40416310 | PubTator, text mining | PubMed |
| Unravelling the role of interleukin-6 in regulating dental stem cell behaviour: a scoping review. | BMC Oral Health | 2025 | 40375224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1749/papers?page=2